{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:22:02Z","timestamp":1781835722601,"version":"3.54.5"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770736"],"award-info":[{"award-number":["81770736"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40265-026-02283-4","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T16:51:48Z","timestamp":1769791908000},"page":"301-319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metabolic Checkpoints in IgA Nephropathy: From Pathogenesis to Precision Medicine"],"prefix":"10.1007","volume":"86","author":[{"given":"Huixia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0476-3198","authenticated-orcid":false,"given":"Jing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"2283_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.semnephrol.2018.05.013","volume":"38","author":"FP Schena","year":"2018","unstructured":"Schena FP, Nistor I. Epidemiology of IgA nephropathy: a global perspective. Semin Nephrol. 2018;38:435\u201342. https:\/\/doi.org\/10.1016\/j.semnephrol.2018.05.013.","journal-title":"Semin Nephrol"},{"key":"2283_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59586-3","volume":"14","author":"N Yang","year":"2024","unstructured":"Yang N, Tang J, Li X,et al. A patient report scale research to access the symptom burden in patients with IgA nephropathy. Sci Rep. 2024;14:22104. https:\/\/doi.org\/10.1038\/s41598-024-59586-3.","journal-title":"Sci Rep"},{"key":"2283_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2023.100759","volume":"6","author":"ME Bensink","year":"2024","unstructured":"Bensink ME, Goldschmidt D, Zhou ZY, et al. Kidney failure attributed to immunoglobulin A nephropathy: a USRDS retrospective cohort study of epidemiology, treatment modalities, and economic burden. Kidney Med. 2024;6:100759. https:\/\/doi.org\/10.1016\/j.xkme.2023.100759.","journal-title":"Kidney Med"},{"key":"2283_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/j.ajkd.2021.01.024","volume":"78","author":"P Pattrapornpisut","year":"2021","unstructured":"Pattrapornpisut P, Avila-Casado C, Reich HN. IgA nephropathy: core curriculum 2021. Am J Kidney Dis. 2021;78:429\u201341. https:\/\/doi.org\/10.1053\/j.ajkd.2021.01.024.","journal-title":"Am J Kidney Dis"},{"key":"2283_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/imr.12855","volume":"295","author":"J Jellusova","year":"2020","unstructured":"Jellusova J. The role of metabolic checkpoint regulators in B cell survival and transformation. Immunol Rev. 2020;295:39\u201353. https:\/\/doi.org\/10.1111\/imr.12855.","journal-title":"Immunol Rev"},{"key":"2283_CR6","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41556-023-01185-x","volume":"25","author":"L Zhang","year":"2023","unstructured":"Zhang L, Jiang C, Zhong Y, et al. STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2. Nat Cell Biol. 2023;25:1208\u201322. https:\/\/doi.org\/10.1038\/s41556-023-01185-x.","journal-title":"Nat Cell Biol"},{"key":"2283_CR7","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1126\/science.aav2588","volume":"366","author":"RD Leone","year":"2019","unstructured":"Leone RD, Zhao L, Englert JM,et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science. 2019;366:1013\u201321. https:\/\/doi.org\/10.1126\/science.aav2588.","journal-title":"Science"},{"key":"2283_CR8","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/s43587-024-00670-8","volume":"4","author":"Z Song","year":"2024","unstructured":"Song Z, Park SH, Mu WC,et al. An NAD(+)-dependent metabolic checkpoint regulates hematopoietic stem cell activation and aging. Nat Aging. 2024;4:1384\u201393. https:\/\/doi.org\/10.1038\/s43587-024-00670-8.","journal-title":"Nat Aging"},{"key":"2283_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.trsl.2024.05.004","volume":"271","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Mi X, Zhang Y,et al. Immune checkpoint activity exacerbate renal interstitial fibrosis progression by enhancing PD-L1 expression in renal tubular epithelial cells. Transl Res. 2024;271:52\u201367. https:\/\/doi.org\/10.1016\/j.trsl.2024.05.004.","journal-title":"Transl Res"},{"key":"2283_CR10","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s10157-014-1070-2","volume":"19","author":"K Yamada","year":"2015","unstructured":"Yamada K, Doi S, Nakashima A,et al. Expression of age-related factors during the development of renal damage in patients with IgA nephropathy. Clin Exp Nephrol. 2015;19:830\u20137. https:\/\/doi.org\/10.1007\/s10157-014-1070-2.","journal-title":"Clin Exp Nephrol"},{"key":"2283_CR11","first-page":"39","volume":"28","author":"L Lai","year":"2019","unstructured":"Lai L, Liu T, Yan M,et al. Abnormal glucose metabolism and galactose-deficient immunoglobulin A1 (IgA1) synthesis: a possible mechanism of IgA nephropathy. Discov Med. 2019;28:39\u201345.","journal-title":"Discov Med"},{"key":"2283_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1338462","volume":"11","author":"Y Yang","year":"2024","unstructured":"Yang Y, Li Y, Feng X, et al. The causal effect of triglyceride and high blood pressure on IgA nephropathy: a Mendelian randomization study. Front Med. 2024;11:1338462. https:\/\/doi.org\/10.3389\/fmed.2024.1338462.","journal-title":"Front Med"},{"key":"2283_CR13","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cmet.2019.11.021","volume":"31","author":"CS Field","year":"2020","unstructured":"Field CS, Baixauli F, Kyle RL, et al. Mitochondrial integrity regulated by lipid metabolism is a cell-intrinsic checkpoint for Treg suppressive function. Cell Metabol. 2020;31:422\u201337. https:\/\/doi.org\/10.1016\/j.cmet.2019.11.021.","journal-title":"Cell Metabol"},{"key":"2283_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/cm9.0000000000000613","volume":"133","author":"YM Zhang","year":"2020","unstructured":"Zhang YM, Zhou XJ, Shi SF, et al. Homocysteine and IgA nephropathy: observational and Mendelian randomization analyses. Chin Med J. 2020;133:277\u201384. https:\/\/doi.org\/10.1097\/cm9.0000000000000613.","journal-title":"Chin Med J"},{"key":"2283_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-70209-9","volume":"14","author":"M Xiao","year":"2024","unstructured":"Xiao M, Chi X, Zhu X, et al. Proteomic analysis of laser captured tubular tissues reveals complement activation and mitochondrial dysfunction in autoimmune related kidney diseases. Sci Rep. 2024;14:19311. https:\/\/doi.org\/10.1038\/s41598-024-70209-9.","journal-title":"Sci Rep"},{"key":"2283_CR16","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.7150\/ijbs.74675","volume":"18","author":"J Wu","year":"2022","unstructured":"Wu J, Shao X, Shen J, et al. Downregulation of PPAR\u03b1 mediates FABP1 expression, contributing to IgA nephropathy by stimulating ferroptosis in human mesangial cells. Int J Biol Sci. 2022;18:5438\u201358. https:\/\/doi.org\/10.7150\/ijbs.74675.","journal-title":"Int J Biol Sci"},{"key":"2283_CR17","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stef\u00e1nsson BV, Correa-Rotter R, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383:1436\u201346. https:\/\/doi.org\/10.1056\/NEJMoa2024816.","journal-title":"N Engl J Med"},{"key":"2283_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"WG Herrington","year":"2023","unstructured":"Herrington WG, Staplin N, Wanner C, et al. Empagliflozin in patients with chronic kidney disease. N Engl J Med. 2023;388:117\u201327. https:\/\/doi.org\/10.1056\/NEJMoa2204233.","journal-title":"N Engl J Med"},{"key":"2283_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-15-110","volume":"15","author":"W Guo","year":"2014","unstructured":"Guo W, Feng JM, Yao L, et al. Transplantation of endothelial progenitor cells in treating rats with IgA nephropathy. BMC Nephrol. 2014;15:110. https:\/\/doi.org\/10.1186\/1471-2369-15-110.","journal-title":"BMC Nephrol"},{"key":"2283_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000355754","volume":"38","author":"R Donderski","year":"2013","unstructured":"Donderski R, Szczepanek J, Domagalski K, et al. Analysis of relative expression level of VEGF (vascular endothelial growth factor), HIF-1\u03b1 (hypoxia inducible factor 1\u03b1) and CTGF (connective tissue growth factor) genes in chronic glomerulonephritis (CGN) patients. Kidney Blood Press Res. 2013;38:83\u201391. https:\/\/doi.org\/10.1159\/000355754.","journal-title":"Kidney Blood Press Res"},{"key":"2283_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1113\/jp280572","volume":"599","author":"SJ Kierans","year":"2021","unstructured":"Kierans SJ, Taylor CT. Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology. J Physiol. 2021;599:23\u201337. https:\/\/doi.org\/10.1113\/jp280572.","journal-title":"J Physiol"},{"key":"2283_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07089-4","volume":"15","author":"ZX Chen","year":"2024","unstructured":"Chen ZX, Mu MY, Yang G,et al. Hypoxia-induced DTL promotes the proliferation, metastasis, and sorafenib resistance of hepatocellular carcinoma through ubiquitin-mediated degradation of SLTM and subsequent Notch pathway activation. Cell Death Dis. 2024;15:734. https:\/\/doi.org\/10.1038\/s41419-024-07089-4.","journal-title":"Cell Death Dis"},{"key":"2283_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111531","volume":"127","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Zhu JH, Zhou Y, et al. Activation of HIF-1\u03b1 C-terminal transactivation domain promotes tubulointerstitial fibrosis through hexokinase 2-mediated metabolic reprogramming. Cell Signal. 2025;127:111531. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111531.","journal-title":"Cell Signal"},{"key":"2283_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1379521","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang X, Du C, et al. Glycolysis and beyond in glucose metabolism: exploring pulmonary fibrosis at the metabolic crossroads. Front Endocrinol. 2024;15:1379521. https:\/\/doi.org\/10.3389\/fendo.2024.1379521.","journal-title":"Front Endocrinol"},{"key":"2283_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246140","author":"AA Tirpe","year":"2019","unstructured":"Tirpe AA, Gulei D, Ciortea SM, et al. Hypoxia: overview on hypoxia-mediated mechanisms with a focus on the role of HIF genes. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20246140.","journal-title":"Int J Mol Sci"},{"key":"2283_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112748","volume":"140","author":"J Qing","year":"2024","unstructured":"Qing J, Li C, Zhi H, et al. Exploring macrophage heterogeneity in IgA nephropathy: mechanisms of renal impairment and current therapeutic targets. Int Immunopharmacol. 2024;140:112748. https:\/\/doi.org\/10.1016\/j.intimp.2024.112748.","journal-title":"Int Immunopharmacol"},{"key":"2283_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/ejpi.EJPI-D-24-00095","volume":"68","author":"H Zou","year":"2025","unstructured":"Zou H, Deng W, Xu L, et al. CircRNA-0013747 promotes mesangial cell proliferation in immunoglobulin A nephropathy through modulation of the Warburg effect. J Physiol Invest. 2025;68:43\u201356. https:\/\/doi.org\/10.4103\/ejpi.EJPI-D-24-00095.","journal-title":"J Physiol Invest"},{"key":"2283_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00151","volume":"9","author":"X Hu","year":"2019","unstructured":"Hu X, Feng J, Zhou Q, et al. Respiratory syncytial virus exacerbates kidney damages in IgA nephropathy mice via the C5a-C5aR1 axis orchestrating Th17 cell responses. Front Cell Infect Microbiol. 2019;9:151. https:\/\/doi.org\/10.3389\/fcimb.2019.00151.","journal-title":"Front Cell Infect Microbiol"},{"key":"2283_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.916934","volume":"13","author":"J Qing","year":"2022","unstructured":"Qing J, Li C, Hu X, et al. Differentiation of T helper 17 cells may mediate the abnormal humoral immunity in IgA nephropathy and inflammatory bowel disease based on shared genetic effects. Front Immunol. 2022;13:916934. https:\/\/doi.org\/10.3389\/fimmu.2022.916934.","journal-title":"Front Immunol"},{"key":"2283_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155832","volume":"155","author":"S Xu","year":"2024","unstructured":"Xu S, Deng KQ, Lu C, et al. Interleukin-6 classic and trans-signaling utilize glucose metabolism reprogramming to achieve anti- or pro-inflammatory effects. Metabolism. 2024;155:155832. https:\/\/doi.org\/10.1016\/j.metabol.2024.155832.","journal-title":"Metabolism"},{"key":"2283_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02765-2","volume":"20","author":"ZM Shi","year":"2023","unstructured":"Shi ZM, Jing JJ, Xue ZJ, et al. Stellate ganglion block ameliorated central post-stroke pain with comorbid anxiety and depression through inhibiting HIF-1\u03b1\/NLRP3 signaling following thalamic hemorrhagic stroke. J Neuroinflammation. 2023;20:82. https:\/\/doi.org\/10.1186\/s12974-023-02765-2.","journal-title":"J Neuroinflammation"},{"key":"2283_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-020-00632-3","volume":"27","author":"YT Lin","year":"2020","unstructured":"Lin YT, Wu KJ. Epigenetic regulation of epithelial-mesenchymal transition: focusing on hypoxia and TGF-\u03b2 signaling. J Biomed Sci. 2020;27:39. https:\/\/doi.org\/10.1186\/s12929-020-00632-3.","journal-title":"J Biomed Sci"},{"key":"2283_CR33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.yexmp.2015.08.004","volume":"99","author":"J Tian","year":"2015","unstructured":"Tian J, Wang Y, Guo H, et al. The Akt\/mTOR\/p70S6K pathway is activated in IgA nephropathy and rapamycin may represent a viable treatment option. Exp Mol Pathol. 2015;99:435\u201340. https:\/\/doi.org\/10.1016\/j.yexmp.2015.08.004.","journal-title":"Exp Mol Pathol"},{"key":"2283_CR34","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.11817\/j.issn.1672-7347.2024.240209","volume":"49","author":"Y Liu","year":"2024","unstructured":"Liu Y, Leng B, Xia M, et al. Regulatory role of the mTOR signaling pathway in autophagy and mesangial proliferation in IgA nephropathy. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024;49:1220\u201331. https:\/\/doi.org\/10.11817\/j.issn.1672-7347.2024.240209.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"2283_CR35","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1177\/1535370214555666","volume":"240","author":"J Tian","year":"2015","unstructured":"Tian J, Wang Y, Liu X, et al. Rapamycin ameliorates IgA nephropathy via cell cycle-dependent mechanisms. Exp Biol Med. 2015;240:936\u201345. https:\/\/doi.org\/10.1177\/1535370214555666.","journal-title":"Exp Biol Med"},{"key":"2283_CR36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000456039","volume":"45","author":"D Liu","year":"2017","unstructured":"Liu D, Liu Y, Chen G, et al. Rapamycin enhances repressed autophagy and attenuates aggressive progression in a rat model of IgA nephropathy. Am J Nephrol. 2017;45:293\u2013300. https:\/\/doi.org\/10.1159\/000456039.","journal-title":"Am J Nephrol"},{"key":"2283_CR37","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.3892\/etm.2018.6480","volume":"16","author":"S Liang","year":"2018","unstructured":"Liang S, Jin J, Shen X, et al. Triptolide protects podocytes via autophagy in immunoglobulin A nephropathy. Exp Ther Med. 2018;16:2275\u201380. https:\/\/doi.org\/10.3892\/etm.2018.6480.","journal-title":"Exp Ther Med"},{"key":"2283_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.106125","volume":"80","author":"M Xia","year":"2020","unstructured":"Xia M, Liu D, Tang X, et al. Dihydroartemisinin inhibits the proliferation of IgAN mesangial cells through the mTOR signaling pathway. Int Immunopharmacol. 2020;80:106125. https:\/\/doi.org\/10.1016\/j.intimp.2019.106125.","journal-title":"Int Immunopharmacol"},{"key":"2283_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.889008","volume":"13","author":"X Zhu","year":"2022","unstructured":"Zhu X, Shen X, Lin B, et al. Liuwei dihuang pills inhibit podocyte injury and alleviate IgA nephropathy by directly altering mesangial cell-derived exosome function and secretion. Front Pharmacol. 2022;13:889008. https:\/\/doi.org\/10.3389\/fphar.2022.889008.","journal-title":"Front Pharmacol"},{"key":"2283_CR40","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","volume":"18","author":"D Montaigne","year":"2021","unstructured":"Montaigne D, Butruille L, Staels B. PPAR control of metabolism and cardiovascular functions. Nat Rev Cardiol. 2021;18:809\u201323. https:\/\/doi.org\/10.1038\/s41569-021-00569-6.","journal-title":"Nat Rev Cardiol"},{"key":"2283_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.125008","volume":"242","author":"M Miao","year":"2023","unstructured":"Miao M, Wang X, Liu T, et al. Targeting PPARs for therapy of atherosclerosis: a review. Int J Biol Macromol. 2023;242:125008. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.125008.","journal-title":"Int J Biol Macromol"},{"key":"2283_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162044","volume":"11","author":"Y Ouyang","year":"2016","unstructured":"Ouyang Y, Xie J, Yang M, et al. Underweight is an independent risk factor for renal function deterioration in patients with IgA nephropathy. PLoS ONE. 2016;11:e0162044. https:\/\/doi.org\/10.1371\/journal.pone.0162044.","journal-title":"PLoS ONE"},{"key":"2283_CR43","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1093\/ndt\/gfn746","volume":"24","author":"J Xiao","year":"2009","unstructured":"Xiao J, Leung JC, Chan LY, et al. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy. Nephrol Dial Transplant. 2009;24:2067\u201377. https:\/\/doi.org\/10.1093\/ndt\/gfn746.","journal-title":"Nephrol Dial Transplant"},{"key":"2283_CR44","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00467-010-1703-y","volume":"26","author":"KN Lai","year":"2011","unstructured":"Lai KN, Chan LY, Guo H, et al. Additive effect of PPAR-\u03b3 agonist and ARB in treatment of experimental IgA nephropathy. Pediatr Nephrol. 2011;26:257\u201366. https:\/\/doi.org\/10.1007\/s00467-010-1703-y.","journal-title":"Pediatr Nephrol"},{"key":"2283_CR45","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1111\/febs.16086","volume":"289","author":"MT Pallotta","year":"2022","unstructured":"Pallotta MT, Rossini S, Suvieri C, et al. Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme. FEBS J. 2022;289:6099\u2013118. https:\/\/doi.org\/10.1111\/febs.16086.","journal-title":"FEBS J"},{"key":"2283_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101573","volume":"75","author":"A Salminen","year":"2022","unstructured":"Salminen A. Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process. Ageing Res Rev. 2022;75:101573. https:\/\/doi.org\/10.1016\/j.arr.2022.101573.","journal-title":"Ageing Res Rev"},{"key":"2283_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006728","author":"M Solvay","year":"2023","unstructured":"Solvay M, Holfelder P, Klaessens S, et al. Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2\/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes. J Immunother Cancer. 2023. https:\/\/doi.org\/10.1136\/jitc-2023-006728.","journal-title":"J Immunother Cancer"},{"key":"2283_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45636-x","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Tu S, Ji X, et al. Dubosiella newyorkensis modulates immune tolerance in colitis via the L-lysine-activated AhR-IDO1-Kyn pathway. Nat Commun. 2024;15:1333. https:\/\/doi.org\/10.1038\/s41467-024-45636-x.","journal-title":"Nat Commun"},{"key":"2283_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00880","volume":"8","author":"EF de Ara\u00fajo","year":"2017","unstructured":"de Ara\u00fajo EF, Feriotti C, Galdino NAL, et al. The IDO-AhR axis controls Th17\/Treg immunity in a pulmonary model of fungal infection. Front Immunol. 2017;8:880. https:\/\/doi.org\/10.3389\/fimmu.2017.00880.","journal-title":"Front Immunol"},{"key":"2283_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.14712\/fb2019065020101","volume":"65","author":"Y Yang","year":"2019","unstructured":"Yang Y, Liu K, Chen Y, et al. Indoleamine 2,3-dioxygenase (IDO) regulates Th17\/Treg immunity in experimental IgA nephropathy. Folia Biol (Praha). 2019;65:101\u20138. https:\/\/doi.org\/10.14712\/fb2019065020101.","journal-title":"Folia Biol (Praha)"},{"key":"2283_CR51","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10157-018-1665-0","volume":"23","author":"J Ruszkowski","year":"2019","unstructured":"Ruszkowski J, Lisowska KA, Pindel M, et al. T cells in IgA nephropathy: role in pathogenesis, clinical significance and potential therapeutic target. Clin Exp Nephrol. 2019;23:291\u2013303. https:\/\/doi.org\/10.1007\/s10157-018-1665-0.","journal-title":"Clin Exp Nephrol"},{"key":"2283_CR52","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41591-018-0060-4","volume":"24","author":"L Laurans","year":"2018","unstructured":"Laurans L, Venteclef N, Haddad Y, et al. Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health. Nat Med. 2018;24:1113\u201320. https:\/\/doi.org\/10.1038\/s41591-018-0060-4.","journal-title":"Nat Med"},{"key":"2283_CR53","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/stmcls\/sxac075","volume":"41","author":"HY Park","year":"2023","unstructured":"Park HY, Kim CE, Lee SM, et al. Priming mesenchymal stem\/stromal cells with a combination of a low dose of IFN-\u03b3 and bortezomib results in potent suppression of pathogenic Th17 immunity through the IDO1-AHR axis. Stem Cells. 2023;41:64\u201376. https:\/\/doi.org\/10.1093\/stmcls\/sxac075.","journal-title":"Stem Cells"},{"key":"2283_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112840","volume":"149","author":"F Niu","year":"2022","unstructured":"Niu F, Yu Y, Li Z, et al. Arginase: an emerging and promising therapeutic target for cancer treatment. Biomed Pharmacother. 2022;149:112840. https:\/\/doi.org\/10.1016\/j.biopha.2022.112840.","journal-title":"Biomed Pharmacother"},{"key":"2283_CR55","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.80721","author":"RE Menjivar","year":"2023","unstructured":"Menjivar RE, Nwosu ZC, Du W, et al. Arginase 1 is a key driver of immune suppression in pancreatic cancer. Elife. 2023. https:\/\/doi.org\/10.7554\/eLife.80721.","journal-title":"Elife"},{"key":"2283_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02888-7","volume":"42","author":"Y Lv","year":"2023","unstructured":"Lv Y, Li M, Weng L, et al. Ginseng-derived nanoparticles reprogram macrophages to regulate arginase-1 release for ameliorating T cell exhaustion in tumor microenvironment. J Exp Clin Cancer Res. 2023;42:322. https:\/\/doi.org\/10.1186\/s13046-023-02888-7.","journal-title":"J Exp Clin Cancer Res"},{"key":"2283_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36163-2","volume":"14","author":"SS Mahalingam","year":"2023","unstructured":"Mahalingam SS, Jayaraman S, Bhaskaran N, et al. Polyamine metabolism impacts T cell dysfunction in the oral mucosa of people living with HIV. Nat Commun. 2023;14:399. https:\/\/doi.org\/10.1038\/s41467-023-36163-2.","journal-title":"Nat Commun"},{"key":"2283_CR58","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.1016\/j.cell.2021.05.045","volume":"184","author":"A Wagner","year":"2021","unstructured":"Wagner A, Wang C, Fessler J, et al. Metabolic modeling of single Th17 cells reveals regulators of autoimmunity. Cell. 2021;184:4168\u201385.e21. https:\/\/doi.org\/10.1016\/j.cell.2021.05.045.","journal-title":"Cell"},{"key":"2283_CR59","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.cmet.2020.01.001","volume":"31","author":"A Yurdagul Jr","year":"2020","unstructured":"Yurdagul A Jr, Subramanian M, Wang X, et al. Macrophage metabolism of apoptotic cell-derived arginine promotes continual efferocytosis and resolution of injury. Cell Metabol. 2020;31:518\u201333.e10. https:\/\/doi.org\/10.1016\/j.cmet.2020.01.001.","journal-title":"Cell Metabol"},{"key":"2283_CR60","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1111\/febs.15715","volume":"288","author":"M Kieler","year":"2021","unstructured":"Kieler M, Hofmann M, Schabbauer G. More than just protein building blocks: how amino acids and related metabolic pathways fuel macrophage polarization. FEBS J. 2021;288:3694\u2013714. https:\/\/doi.org\/10.1111\/febs.15715.","journal-title":"FEBS J"},{"key":"2283_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.646650","volume":"12","author":"M Yang","year":"2021","unstructured":"Yang M, Liu JW, Zhang YT, et al. The role of renal macrophage, AIM, and TGF-\u03b21 expression in renal fibrosis progression in IgAN patients. Front Immunol. 2021;12:646650. https:\/\/doi.org\/10.3389\/fimmu.2021.646650.","journal-title":"Front Immunol"},{"key":"2283_CR62","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1042\/cs20200799","volume":"134","author":"B Pang","year":"2020","unstructured":"Pang B, Zhen Y, Hu C, et al. Myeloid-derived suppressor cells shift Th17\/Treg ratio and promote systemic lupus erythematosus progression through arginase-1\/miR-322-5p\/TGF-\u03b2 pathway. Clin Sci (Lond). 2020;134:2209\u201322. https:\/\/doi.org\/10.1042\/cs20200799.","journal-title":"Clin Sci (Lond)"},{"key":"2283_CR63","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1042\/cs20210778","volume":"36","author":"L Liang","year":"2022","unstructured":"Liang L, Liu L, Zhou W, et al. Gut microbiota-derived butyrate regulates gut mucus barrier repair by activating the macrophage\/WNT\/ERK signaling pathway. Clin Sci. 2022;36:291\u2013307. https:\/\/doi.org\/10.1042\/cs20210778.","journal-title":"Clin Sci"},{"key":"2283_CR64","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl6149","volume":"6","author":"PJ Gleeson","year":"2024","unstructured":"Gleeson PJ, Benech N, Chemouny J, et al. The gut microbiota posttranslationally modifies IgA1 in autoimmune glomerulonephritis. Sci Transl Med. 2024;6:eadl6149. https:\/\/doi.org\/10.1126\/scitranslmed.adl6149.","journal-title":"Sci Transl Med"},{"key":"2283_CR65","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.freeradbiomed.2024.10.313","volume":"225","author":"J Kim","year":"2024","unstructured":"Kim J, Lee JH, Jang SH, et al. SBP1 contributes to mesangial proliferation and inflammation through mitochondrial respiration in glomerulus during IgA nephropathy. Free Radic Biol Med. 2024;225:711\u201325. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.10.313.","journal-title":"Free Radic Biol Med"},{"key":"2283_CR66","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.7150\/ijbs.85674","volume":"19","author":"Q Feng","year":"2023","unstructured":"Feng Q, Yang Y, Ren K, et al. Broadening horizons: the multifaceted functions of ferroptosis in kidney diseases. Int J Biol Sci. 2023;19:3726\u201343. https:\/\/doi.org\/10.7150\/ijbs.85674.","journal-title":"Int J Biol Sci"},{"key":"2283_CR67","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1440-1681.2008.05107.x","volume":"36","author":"N Ohashi","year":"2009","unstructured":"Ohashi N, Katsurada A, Miyata K, et al. Activation of reactive oxygen species and the renin-angiotensin system in IgA nephropathy model mice. Clin Exp Pharmacol Physiol. 2009;36:509\u201315. https:\/\/doi.org\/10.1111\/j.1440-1681.2008.05107.x.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2283_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077794","volume":"8","author":"KF Hua","year":"2013","unstructured":"Hua KF, Yang SM, Kao TY, et al. Osthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-\u03baB\/NLRP3 pathway. PLoS ONE. 2013;8:e77794. https:\/\/doi.org\/10.1371\/journal.pone.0077794.","journal-title":"PLoS ONE"},{"key":"2283_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/srep41123","volume":"7","author":"YL Tsai","year":"2017","unstructured":"Tsai YL, Hua KF, Chen A, et al. NLRP3 inflammasome: pathogenic role and potential therapeutic target for IgA nephropathy. Sci Rep. 2017;7:41123. https:\/\/doi.org\/10.1038\/srep41123.","journal-title":"Sci Rep"},{"key":"2283_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59010082","author":"X Wu","year":"2022","unstructured":"Wu X, Zhao L, Li K, et al. The role of NLRP3 inflammasome in IgA nephropathy. Medicina (Kaunas). 2022. https:\/\/doi.org\/10.3390\/medicina59010082.","journal-title":"Medicina (Kaunas)"},{"key":"2283_CR71","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.biocel.2014.09.018","volume":"57","author":"D Liu","year":"2014","unstructured":"Liu D, Xu M, Ding LH, et al. Activation of the Nlrp3 inflammasome by mitochondrial reactive oxygen species: a novel mechanism of albumin-induced tubulointerstitial inflammation. Int J Biochem Cell Biol. 2014;57:7\u201319. https:\/\/doi.org\/10.1016\/j.biocel.2014.09.018.","journal-title":"Int J Biochem Cell Biol"},{"key":"2283_CR72","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.biopha.2018.10.161","volume":"109","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Yang X, Ge X, et al. Puerarin attenuates neurological deficits via Bcl-2\/Bax\/cleaved caspase-3 and Sirt3\/SOD2 apoptotic pathways in subarachnoid hemorrhage mice. Biomed Pharmacother. 2019;109:726\u201333. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.161.","journal-title":"Biomed Pharmacother"},{"key":"2283_CR73","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/cdd.2017.144","volume":"25","author":"J Gao","year":"2018","unstructured":"Gao J, Feng Z, Wang X, et al. SIRT3\/SOD2 maintains osteoblast differentiation and bone formation by regulating mitochondrial stress. Cell Death Differ. 2018;25:229\u201340. https:\/\/doi.org\/10.1038\/cdd.2017.144.","journal-title":"Cell Death Differ"},{"key":"2283_CR74","doi-asserted-by":"publisher","first-page":"13609","DOI":"10.1111\/jcmm.15663","volume":"24","author":"CY Wu","year":"2020","unstructured":"Wu CY, Hua KF, Yang SR, et al. Tris DBA ameliorates IgA nephropathy by blunting the activating signal of NLRP3 inflammasome through SIRT1- and SIRT3-mediated autophagy induction. J Cell Mol Med. 2020;24:13609\u201322. https:\/\/doi.org\/10.1111\/jcmm.15663.","journal-title":"J Cell Mol Med"},{"key":"2283_CR75","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/moh.0000000000000244","volume":"23","author":"M Mohrin","year":"2016","unstructured":"Mohrin M, Chen D. The mitochondrial metabolic checkpoint and aging of hematopoietic stem cells. Curr Opin Hematol. 2016;23:318\u201324. https:\/\/doi.org\/10.1097\/moh.0000000000000244.","journal-title":"Curr Opin Hematol"},{"key":"2283_CR76","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000021372","volume":"99","author":"SL Hu","year":"2020","unstructured":"Hu SL, Wang D, Yuan FL, et al. Identification of key genes and pathways in IgA nephropathy using bioinformatics analysis. Medicine. 2020;99:e21372. https:\/\/doi.org\/10.1097\/md.0000000000021372.","journal-title":"Medicine"},{"key":"2283_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101702","volume":"81","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Fan Y, Zong R, et al. The mitochondrial unfolded protein response: a multitasking giant in the fight against human diseases. Ageing Res Rev. 2022;81:101702. https:\/\/doi.org\/10.1016\/j.arr.2022.101702.","journal-title":"Ageing Res Rev"},{"key":"2283_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105603","volume":"168","author":"L Zhu","year":"2021","unstructured":"Zhu L, Luo X, Fu N, et al. Mitochondrial unfolded protein response: a novel pathway in metabolism and immunity. Pharmacol Res. 2021;168:105603. https:\/\/doi.org\/10.1016\/j.phrs.2021.105603.","journal-title":"Pharmacol Res"},{"key":"2283_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109840","volume":"257","author":"Z Lan","year":"2023","unstructured":"Lan Z, Zhao L, Peng L, et al. EIF2\u03b1\/ATF4 pathway enhances proliferation of mesangial cell via cyclin D1 during endoplasmic reticulum stress in IgA nephropathy. Clin Immunol. 2023;257:109840. https:\/\/doi.org\/10.1016\/j.clim.2023.109840.","journal-title":"Clin Immunol"},{"key":"2283_CR80","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1159\/000495061","volume":"50","author":"X Peng","year":"2018","unstructured":"Peng X, Yang T, He L, et al. Impact of GADD34 on apoptosis of tonsillar mononuclear cells from IgA nephropathy patients by regulating Eif2\u03b1 phosphorylation. Cell Physiol Biochem. 2018;50:2203\u201315. https:\/\/doi.org\/10.1159\/000495061.","journal-title":"Cell Physiol Biochem"},{"key":"2283_CR81","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/s0140-6736(23)01554-4","volume":"402","author":"R Lafayette","year":"2023","unstructured":"Lafayette R, Kristensen J, Stone A, et al. Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial. Lancet. 2023;402:859\u201370. https:\/\/doi.org\/10.1016\/s0140-6736(23)01554-4.","journal-title":"Lancet"},{"key":"2283_CR82","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.2147\/dddt.S383138","volume":"18","author":"J Barratt","year":"2024","unstructured":"Barratt J, Kristensen J, Pedersen C, et al. Insights on Nefecon\u00ae, a targeted-release formulation of budesonide and its selective immunomodulatory effects in patients with IgA nephropathy. Drug Des Dev Ther. 2024;18:3415\u201328. https:\/\/doi.org\/10.2147\/dddt.S383138.","journal-title":"Drug Des Dev Ther"},{"key":"2283_CR83","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/gut.48.4.571","volume":"48","author":"SG Nugent","year":"2001","unstructured":"Nugent SG, Kumar D, Rampton DS, et al. Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs. Gut. 2001;48:571\u20137. https:\/\/doi.org\/10.1136\/gut.48.4.571.","journal-title":"Gut"},{"key":"2283_CR84","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2022.11526","volume":"24","author":"X Zhang","year":"2022","unstructured":"Zhang X, Wang G, Shen D, et al. Protective effects of budesonide on LPS-induced podocyte injury by modulating macrophage M1\/M2 polarization: evidence from in vitro and in silico studies. Exp Ther Med. 2022;24:589. https:\/\/doi.org\/10.3892\/etm.2022.11526.","journal-title":"Exp Ther Med"},{"key":"2283_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03402-x","volume":"20","author":"HO Nguyen","year":"2022","unstructured":"Nguyen HO, Salvi V, Tiberio L, et al. The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulation. J Transl Med. 2022;20:203. https:\/\/doi.org\/10.1186\/s12967-022-03402-x.","journal-title":"J Transl Med"},{"key":"2283_CR86","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1056\/NEJMoa2410316","volume":"392","author":"V Perkovic","year":"2025","unstructured":"Perkovic V, Barratt J, Rovin B, et al. Alternative complement pathway inhibition with iptacopan in IgA nephropathy. N Engl J Med. 2025;392:531\u201343. https:\/\/doi.org\/10.1056\/NEJMoa2410316.","journal-title":"N Engl J Med"},{"key":"2283_CR87","doi-asserted-by":"publisher","first-page":"ii28","DOI":"10.1093\/ckj\/sfad198","volume":"16","author":"F Caravaca-Font\u00e1n","year":"2023","unstructured":"Caravaca-Font\u00e1n F, Guti\u00e9rrez E, Sevillano \u00c1M, et al. Targeting complement in IgA nephropathy. Clin Kidney J. 2023;16:ii28\u201339. https:\/\/doi.org\/10.1093\/ckj\/sfad198.","journal-title":"Clin Kidney J"},{"key":"2283_CR88","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s10571-022-01275-8","volume":"43","author":"L Wang","year":"2023","unstructured":"Wang L, Sun Y, Kong F, et al. Mild hypothermia alleviates complement C5a-induced neuronal autophagy during brain ischemia-reperfusion injury after cardiac arrest. Cell Mol Neurobiol. 2023;43:1957\u201374. https:\/\/doi.org\/10.1007\/s10571-022-01275-8.","journal-title":"Cell Mol Neurobiol"},{"key":"2283_CR89","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2337\/db19-0043","volume":"69","author":"SM Tan","year":"2020","unstructured":"Tan SM, Ziemann M, Thallas-Bonke V, et al. Complement C5a induces renal injury in diabetic kidney disease by disrupting mitochondrial metabolic agility. Diabetes. 2020;69:83\u201398. https:\/\/doi.org\/10.2337\/db19-0043.","journal-title":"Diabetes"},{"key":"2283_CR90","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.smim.2018.02.006","volume":"37","author":"MK Pandey","year":"2018","unstructured":"Pandey MK, Grabowski GA, K\u00f6hl J. An unexpected player in Gaucher disease: the multiple roles of complement in disease development. Semin Immunol. 2018;37:30\u201342. https:\/\/doi.org\/10.1016\/j.smim.2018.02.006.","journal-title":"Semin Immunol"},{"key":"2283_CR91","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/13543784.2024.2414902","volume":"33","author":"H Nagasawa","year":"2024","unstructured":"Nagasawa H, Suzuki H, Ueda S, et al. Dual blockade of endothelin A and angiotensin II type 1 receptors with sparsentan as a novel treatment strategy to alleviate IgA nephropathy. Expert Opin Investig Drugs. 2024;33:1143\u201352. https:\/\/doi.org\/10.1080\/13543784.2024.2414902.","journal-title":"Expert Opin Investig Drugs"},{"key":"2283_CR92","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s40265-025-02208-7","volume":"85","author":"SJ Keam","year":"2025","unstructured":"Keam SJ. Atrasentan: first approval. Drugs. 2025;85:1311\u20137. https:\/\/doi.org\/10.1007\/s40265-025-02208-7.","journal-title":"Drugs"},{"key":"2283_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213816","author":"S Pandey","year":"2022","unstructured":"Pandey S, Madreiter-Sokolowski CT, Mangmool S, et al. High glucose-induced cardiomyocyte damage involves interplay between endothelin ET-1\/ET(A)\/ET(B) receptor and mTOR pathway. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232213816.","journal-title":"Int J Mol Sci"},{"key":"2283_CR94","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1161\/01.Cir.0000112596.06954.00","volume":"109","author":"Y Irukayama-Tomobe","year":"2004","unstructured":"Irukayama-Tomobe Y, Miyauchi T, Sakai S, et al. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway. Circulation. 2004;109:904\u201310. https:\/\/doi.org\/10.1161\/01.Cir.0000112596.06954.00.","journal-title":"Circulation"},{"key":"2283_CR95","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1016\/j.bbadis.2018.07.020","volume":"1864","author":"AF Ceylan","year":"2018","unstructured":"Ceylan AF, Wang S, Kandadi MR, et al. Cardiomyocyte-specific knockout of endothelin receptor a attenuates obesity cardiomyopathy. Biochimica et Biophysica Acta (BBA) Mol Basis Dis. 2018;1864:3339\u201352. https:\/\/doi.org\/10.1016\/j.bbadis.2018.07.020.","journal-title":"Biochimica et Biophysica Acta (BBA) Mol Basis Dis"},{"key":"2283_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60558-6","volume":"10","author":"RM Chaphalkar","year":"2020","unstructured":"Chaphalkar RM, Stankowska DL, He S, et al. Endothelin-1 mediated decrease in mitochondrial gene expression and bioenergetics contribute to neurodegeneration of retinal ganglion cells. Sci Rep. 2020;10:3571. https:\/\/doi.org\/10.1038\/s41598-020-60558-6.","journal-title":"Sci Rep"},{"key":"2283_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12122060","author":"S Yan","year":"2023","unstructured":"Yan S, Sheak JR, Walker BR, et al. Contribution of mitochondrial reactive oxygen species to chronic hypoxia-induced pulmonary hypertension. Antioxidants (Basel). 2023. https:\/\/doi.org\/10.3390\/antiox12122060.","journal-title":"Antioxidants (Basel)"},{"key":"2283_CR98","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1681\/asn.0000000000000242","volume":"35","author":"K El Karoui","year":"2024","unstructured":"El Karoui K, Fervenza FC, De Vriese AS. Treatment of IgA nephropathy: a rapidly evolving field. J Am Soc Nephrol. 2024;35:103\u201316. https:\/\/doi.org\/10.1681\/asn.0000000000000242.","journal-title":"J Am Soc Nephrol"},{"key":"2283_CR99","doi-asserted-by":"publisher","first-page":"C243","DOI":"10.1152\/ajpcell.00147.2023","volume":"325","author":"B Lee","year":"2023","unstructured":"Lee B, Holstein-Rathlou NH, Sosnovtseva O, et al. Renoprotective effects of GLP-1 receptor agonists and SGLT-2 inhibitors: is hemodynamics the key point? Am J Physiol Cell Physiol. 2023;325:C243\u201356. https:\/\/doi.org\/10.1152\/ajpcell.00147.2023.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2283_CR100","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98720","author":"P Cassis","year":"2018","unstructured":"Cassis P, Locatelli M, Cerullo D, et al. SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy. JCI Insight. 2018. https:\/\/doi.org\/10.1172\/jci.insight.98720.","journal-title":"JCI Insight"},{"key":"2283_CR101","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.kint.2021.03.033","volume":"100","author":"DC Wheeler","year":"2021","unstructured":"Wheeler DC, Toto RD, Stef\u00e1nsson BV, et al. A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy. Kidney Int. 2021;100:215\u201324. https:\/\/doi.org\/10.1016\/j.kint.2021.03.033.","journal-title":"Kidney Int"},{"key":"2283_CR102","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1080\/0886022x.2019.1577257","volume":"41","author":"N Guo","year":"2019","unstructured":"Guo N, Liu S, Bow LM, et al. The protective effect and mechanism of rapamycin in the rat model of IgA nephropathy. Ren Fail. 2019;41:334\u20139. https:\/\/doi.org\/10.1080\/0886022x.2019.1577257.","journal-title":"Ren Fail"},{"issue":"3","key":"2283_CR103","doi-asserted-by":"publisher","first-page":"CD003965","DOI":"10.1002\/14651858.CD003965.pub3","volume":"3","author":"P Natale","year":"2020","unstructured":"Natale P, Palmer SC, Ruospo M, et al. Immunosuppressive agents for treating IgA nephropathy. Cochrane Database Syst Rev. 2020;3(3):CD003965. https:\/\/doi.org\/10.1002\/14651858.CD003965.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"2283_CR104","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13207","volume":"32","author":"MC Di Vico","year":"2018","unstructured":"Di Vico MC, Messina M, Fop F, et al. Recurrent IgA nephropathy after renal transplantation and steroid withdrawal. Clin Transplant. 2018;32:e13207. https:\/\/doi.org\/10.1111\/ctr.13207.","journal-title":"Clin Transplant"},{"key":"2283_CR105","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.biopha.2018.02.127","volume":"101","author":"B Liu","year":"2018","unstructured":"Liu B, He Y, Lu R, et al. Zhen-wu-tang protects against podocyte injury in rats with IgA nephropathy via PPAR\u03b3\/NF-\u03baB pathway. Biomed Pharmacother. 2018;101:635\u201347. https:\/\/doi.org\/10.1016\/j.biopha.2018.02.127.","journal-title":"Biomed Pharmacother"},{"key":"2283_CR106","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.7150\/thno.65427","volume":"12","author":"K Sundaram","year":"2022","unstructured":"Sundaram K, Mu J, Kumar A, et al. Garlic exosome-like nanoparticles reverse high-fat diet induced obesity via the gut\/brain axis. Theranostics. 2022;12:1220\u201346. https:\/\/doi.org\/10.7150\/thno.65427.","journal-title":"Theranostics"},{"key":"2283_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116176","author":"A Krupa","year":"2022","unstructured":"Krupa A, Krupa MM, Pawlak K. Indoleamine 2,3 dioxygenase 1: the potential link between the innate immunity and the ischemia-reperfusion-induced acute kidney injury? Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23116176.","journal-title":"Int J Mol Sci"},{"key":"2283_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/cells11162604","author":"A Krupa","year":"2022","unstructured":"Krupa A, Krupa MM, Pawlak K. Kynurenine pathway: an underestimated factor modulating innate immunity in sepsis-induced acute kidney injury? Cells. 2022. https:\/\/doi.org\/10.3390\/cells11162604.","journal-title":"Cells"},{"key":"2283_CR109","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1681\/asn.2020091310","volume":"32","author":"JA Walker","year":"2021","unstructured":"Walker JA, Richards S, Whelan SA, et al. Indoleamine 2,3-dioxygenase-1, a novel therapeutic target for post-vascular injury thrombosis in CKD. J Am Soc Nephrol. 2021;32:2834\u201350. https:\/\/doi.org\/10.1681\/asn.2020091310.","journal-title":"J Am Soc Nephrol"},{"key":"2283_CR110","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.7150\/thno.50905","volume":"11","author":"M Zhao","year":"2021","unstructured":"Zhao M, Wang Y, Li L, et al. Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance. Theranostics. 2021;11:1845\u201363. https:\/\/doi.org\/10.7150\/thno.50905.","journal-title":"Theranostics"},{"key":"2283_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.pestbp.2024.105904","volume":"201","author":"G Zhong","year":"2024","unstructured":"Zhong G, Qiao B, He Y, et al. Co-exposure of arsenic and polystyrene-nanoplastics induced kidney injury by disrupting mitochondrial homeostasis and mtROS-mediated ferritinophagy and ferroptosis. Pestic Biochem Physiol. 2024;201:105904. https:\/\/doi.org\/10.1016\/j.pestbp.2024.105904.","journal-title":"Pestic Biochem Physiol"},{"key":"2283_CR112","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.bja.2021.05.036","volume":"127","author":"N Arulkumaran","year":"2021","unstructured":"Arulkumaran N, Pollen SJ, Tidswell R, et al. Selective mitochondrial antioxidant MitoTEMPO reduces renal dysfunction and systemic inflammation in experimental sepsis in rats. Br J Anaesth. 2021;127:577\u201386. https:\/\/doi.org\/10.1016\/j.bja.2021.05.036.","journal-title":"Br J Anaesth"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-026-02283-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-026-02283-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-026-02283-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:35:51Z","timestamp":1772764551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-026-02283-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":112,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2283"],"URL":"https:\/\/doi.org\/10.1007\/s40265-026-02283-4","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Huixia Liu, Ye Yao, Chun Zhang, and Jing Xiong have no conflicts of interest that are directly relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"HL: conceptualization, literature search and analysis, writing (original draft preparation), writing (review and editing). YY: reviewing, editing, visualization. CZ: reviewing, editing, visualization. JX: conceptualization, visualization, funding acquisition. All authors have read and approved the final version of the article.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}